Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models.

MLA

Fabian, Kellsye P., et al. “Alum-Anchored IL-12 Combined with Cytotoxic Chemotherapy and Immune Checkpoint Blockade Enhanced Antitumor Immune Responses in Head and Neck Cancer Models.” Journal for Immunotherapy of Cancer, vol. 12, no. 10, Oct. 2024. EBSCOhost, https://doi.org/10.1136/jitc-2024-009712.

APA

Fabian, K. P., Santiago-Sanchez, G., Padget, M. R., Lassoued, W., Allen, C. T., Battula, S., Kaufman, H., & Hodge, J. W. (2024). Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models. Journal for Immunotherapy of Cancer, 12(10). https://doi.org/10.1136/jitc-2024-009712

Chicago

Fabian, Kellsye P, Ginette Santiago-Sanchez, Michelle R Padget, Wiem Lassoued, Clint Tanner Allen, Sailaja Battula, Howard Kaufman, and James W Hodge. 2024. “Alum-Anchored IL-12 Combined with Cytotoxic Chemotherapy and Immune Checkpoint Blockade Enhanced Antitumor Immune Responses in Head and Neck Cancer Models.” Journal for Immunotherapy of Cancer 12 (10). doi:10.1136/jitc-2024-009712.